论文部分内容阅读
INTRODUCTION Clinically, transarterial chemoembolization （TACE） has been most widely used for unresectable hepatocellular carcinoma （HCC）. Although TACE is an effective treatment for HCC, it carries several potential side effects such as hepatic failure,